80043069 - OncologyConsults.com - New and Emerging Targeted Therapy Options for Treating Metastatic Renal Cell Carcinoma



Date & Location
Monday, December 3, 2018, 10:27 AM - Thursday, December 3, 2020, 11:27 AM

Overview
This online activity addresses the following topics: 1. Available mRCC Targeted Therapy Armamentarium a. Targeted therapy pharmacology b. Safety and efficacy 2. Implementing Personalized Treatment a. Initial and progressive therapy selection b. Combination and sequential therapy incorporating chemo-, tareted-, and immuno-therapy i. Current recommendations ii. Ongoing and late-stage trials exploring novel combinations and sequences

https://www.oncologyconsults.com/Home/CEData?id=782
Objectives
Upon completion of this activity, the learner will demonstrate the ability to:

  1. Identify the efficacy and safety of novel and investigational mRCC targeted therapies
  2. Incorporate mRCC targeted therapies into individualized treatment plans based on current treatment algorithms and recommendations

Accreditation
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Keywords: ONLINE